{"id":"placebo-for-esomeprazole","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5314366","moleculeType":"Small molecule","molecularWeight":"769.20"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials. Any observed effects result from patient expectation, the therapeutic context, and natural disease progression rather than direct molecular action. In this case, it serves as a control comparator for esomeprazole efficacy studies.","oneSentence":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:47.260Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in esomeprazole clinical trials (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT04448028","phase":"PHASE4","title":"Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial","status":"RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2021-04-22","conditions":"Liver Cirrhosis","enrollment":476},{"nctId":"NCT06903585","phase":"PHASE2","title":"Non Steroidal Anti-inflammatory Drugs in the Prevention of Bone Pain Flares After Palliative Radiotherapy","status":"NOT_YET_RECRUITING","sponsor":"American University of Beirut Medical Center","startDate":"2025-04","conditions":"Bone Pain Flare, Bone Metastasis","enrollment":385},{"nctId":"NCT05664685","phase":"PHASE4","title":"Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-10-17","conditions":"Helicobacter Pylori Infection","enrollment":127},{"nctId":"NCT01216293","phase":"PHASE1","title":"Effect of Dexlansoprazole on Bone Homeostasis","status":"COMPLETED","sponsor":"Takeda","startDate":"2010-11-01","conditions":"Homeostasis, Bone and Bones","enrollment":115},{"nctId":"NCT03452865","phase":"PHASE3","title":"Esomeprazole to Reduce Organ Failure in Sepsis","status":"COMPLETED","sponsor":"Università Vita-Salute San Raffaele","startDate":"2020-01-28","conditions":"Sepsis, Septic Shock","enrollment":300},{"nctId":"NCT05577468","phase":"PHASE3","title":"Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2022-10-30","conditions":"Helicobacter Pylori Infection","enrollment":561},{"nctId":"NCT02476097","phase":"PHASE4","title":"PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms","status":"UNKNOWN","sponsor":"Victoria Rollason","startDate":"2015-06","conditions":"Stomach Diseases","enrollment":58},{"nctId":"NCT05841394","phase":"PHASE3","title":"A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding","status":"COMPLETED","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2021-07-16","conditions":"Stress Ulcer Bleeding","enrollment":449},{"nctId":"NCT02081404","phase":"NA","title":"Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study","status":"COMPLETED","sponsor":"Midwest Biomedical Research Foundation","startDate":"2009-03-01","conditions":"Non-erosive Reflux Disease","enrollment":98},{"nctId":"NCT05662514","phase":"NA","title":"Effect of Probiotics on Gut Microbiota During the Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-02-15","conditions":"Helicobacter Pylori Infection, Gut Microbiota","enrollment":100},{"nctId":"NCT04769583","phase":"PHASE4","title":"14-day Quadruple Therapy Versus Triple Therapy in HP Eradication","status":"COMPLETED","sponsor":"mohamed bouchoucha","startDate":"2019-02-10","conditions":"Gastritis H Pylori","enrollment":121},{"nctId":"NCT00978016","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)","status":"COMPLETED","sponsor":"XenoPort, Inc.","startDate":"2009-09","conditions":"Gastroesophageal Reflux Disease","enrollment":460},{"nctId":"NCT04080726","phase":"PHASE3","title":"Efficacy and Safety of HIP1601 Capsule","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-10-25","conditions":"Erosive Gastroesophageal Reflux Disease","enrollment":213},{"nctId":"NCT03736369","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2018-12-13","conditions":"Erosive Esophagitis","enrollment":263},{"nctId":"NCT03615677","phase":"PHASE3","title":"Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2018-10-24","conditions":"Erosive Esophagitis (EE)","enrollment":261},{"nctId":"NCT00719160","phase":"PHASE4","title":"The Effect of Protein on Calcium Absorption and Gastric Acid Production","status":"COMPLETED","sponsor":"Yale University","startDate":"2005-01","conditions":"Osteoporosis","enrollment":12},{"nctId":"NCT04142762","phase":"PHASE1","title":"A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults","status":"COMPLETED","sponsor":"Assembly Biosciences","startDate":"2019-10-18","conditions":"Chronic Hepatitis B","enrollment":80},{"nctId":"NCT02743949","phase":"PHASE2","title":"Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)","status":"COMPLETED","sponsor":"Takeda","startDate":"2016-07-14","conditions":"Gastroesophageal Reflux","enrollment":256},{"nctId":"NCT02637557","phase":"PHASE2","title":"A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)","status":"COMPLETED","sponsor":"Ironwood Pharmaceuticals, Inc.","startDate":"2016-03-01","conditions":"Gastroesophageal Reflux Disease","enrollment":282},{"nctId":"NCT00745849","phase":"NA","title":"Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2005-06","conditions":"Vasomotor Rhinitis","enrollment":43},{"nctId":"NCT01670552","phase":"PHASE3","title":"Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients","status":"COMPLETED","sponsor":"EMS","startDate":"2016-02-17","conditions":"Acute and Chronic Inflammation, Dyspepsia","enrollment":490},{"nctId":"NCT00951431","phase":"PHASE4","title":"Gastric Functions & Proton Pump Inhibitor( PPI) Study","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2009-12-03","conditions":"Functional Dyspepsia","enrollment":155},{"nctId":"NCT01349413","phase":"PHASE4","title":"BRAVO Study for Functional Dyspepsia","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2011-08-24","conditions":"Dyspepsia, Gastroesophageal Reflux","enrollment":130},{"nctId":"NCT03717740","phase":"PHASE3","title":"Esomeprazole for the Prevention of Preeclampsia","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":"Pre-Eclampsia","enrollment":1000},{"nctId":"NCT00206440","phase":"PHASE3","title":"Nexium Study To Suppress Nausea During Chemotherapy","status":"TERMINATED","sponsor":"Baylor Breast Care Center","startDate":"2005-08","conditions":"Nausea","enrollment":43},{"nctId":"NCT03722433","phase":"PHASE4","title":"Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2018-08-29","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT02757144","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2016-03","conditions":"Healthy","enrollment":120},{"nctId":"NCT00153660","phase":"PHASE3","title":"Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2005-06","conditions":"Arthritis, Cardiovascular Diseases, Cerebrovascular Disorders","enrollment":514},{"nctId":"NCT02984930","phase":"NA","title":"Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease","status":"UNKNOWN","sponsor":"Gangnam Severance Hospital","startDate":"2016-12","conditions":"Gastroesophageal Reflux Disease","enrollment":30},{"nctId":"NCT00361985","phase":"PHASE4","title":"Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2008-01","conditions":"Anastomotic Stricture, Morbid Obesity","enrollment":""},{"nctId":"NCT01873079","phase":"PHASE3","title":"PPI for Prevention of Post-sphincterotomy Bleeding","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2013-04","conditions":"Bleeding, ERCP","enrollment":185},{"nctId":"NCT01888549","phase":"NA","title":"Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2012-02","conditions":"Chronic Cough Caused by Gastroesophageal Reflux","enrollment":48},{"nctId":"NCT02703896","phase":"PHASE4","title":"Prophylaxis for Aspiration of Gastric Contents.","status":"COMPLETED","sponsor":"King Saud University","startDate":"2012-01","conditions":"Pulmonary Aspiration of Gastric Contents","enrollment":1920},{"nctId":"NCT00444236","phase":"PHASE1","title":"Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression","status":"TERMINATED","sponsor":"University of Utah","startDate":"2007-04","conditions":"Exercise Triggered Asthma, Gastroesophageal Reflux","enrollment":31},{"nctId":"NCT02134405","phase":"PHASE4","title":"Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia","status":"UNKNOWN","sponsor":"University of Malaya","startDate":"2014-08","conditions":"Dyspepsia","enrollment":200},{"nctId":"NCT02620696","phase":"PHASE1","title":"Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin","status":"COMPLETED","sponsor":"Trio Medicines Ltd.","startDate":"2009-11","conditions":"ECL-cell Hyperplasia, Parietal-cell Hyperplasia, Rebound Hyperacidity","enrollment":48},{"nctId":"NCT01142245","phase":"PHASE3","title":"Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2008-01","conditions":"Peptic Ulcer, Bleeding","enrollment":263},{"nctId":"NCT02355236","phase":"PHASE4","title":"Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis","status":"UNKNOWN","sponsor":"Severance Hospital","startDate":"2015-02","conditions":"Osteoarthritis","enrollment":106},{"nctId":"NCT01750437","phase":"PHASE2","title":"Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2013-01","conditions":"Non-erosive Reflux Disease","enrollment":149},{"nctId":"NCT00468559","phase":"PHASE3","title":"Phase 3/Safety & Efficacy of Esomeprazole in Infants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-04","conditions":"Gastroesophageal Reflux Disease (GERD)","enrollment":98},{"nctId":"NCT00464308","phase":"PHASE4","title":"A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg","status":"COMPLETED","sponsor":"Janssen-Cilag Pty Ltd","startDate":"2006-11","conditions":"Gastro-oesophageal Reflux","enrollment":1392},{"nctId":"NCT00567658","phase":"PHASE3","title":"Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas","status":"WITHDRAWN","sponsor":"Vanderbilt University","startDate":"2008-02","conditions":"Larynx Disease","enrollment":""},{"nctId":"NCT01142128","phase":"PHASE1","title":"Viokase 16, Viokase16 Plus Nexium and Nexium Alone","status":"TERMINATED","sponsor":"University of Florida","startDate":"2009-02","conditions":"Chronic Pancreatitis","enrollment":12},{"nctId":"NCT00069823","phase":"PHASE3","title":"Study of Acid Reflux in Asthma","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2003-09","conditions":"Asthma, Lung Diseases, Lung Diseases, Obstructive","enrollment":403},{"nctId":"NCT01069939","phase":"PHASE3","title":"Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-02","conditions":"Prevention","enrollment":427},{"nctId":"NCT00287339","phase":"PHASE4","title":"The Utility of Nexium in Chronic Cough and Reflux Disease","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2005-09","conditions":"Cough, GERD","enrollment":40},{"nctId":"NCT00546065","phase":"NA","title":"APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation","status":"TERMINATED","sponsor":"HSK Wiesbaden","startDate":"2006-08","conditions":"Barrett's Esophagus","enrollment":68},{"nctId":"NCT00641004","phase":"PHASE4","title":"Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical, Inc., Philippines","startDate":"2008-04","conditions":"NSAID Induced Gastropathy","enrollment":30},{"nctId":"NCT00730665","phase":"PHASE2","title":"Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)","status":"TERMINATED","sponsor":"Pfizer","startDate":"2008-01","conditions":"Gastroesophageal Reflux Disease","enrollment":81},{"nctId":"NCT00251979","phase":"PHASE3","title":"A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2005-10","conditions":"Gastrointestinal Hemorrhage","enrollment":1312},{"nctId":"NCT00786695","phase":"NA","title":"Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2006-05","conditions":"Gastroesophageal Reflux Disease","enrollment":60},{"nctId":"NCT00629928","phase":"PHASE3","title":"Ulcer Prevention II","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2001-02","conditions":"NSAID Associated Gastric Ulcers","enrollment":800},{"nctId":"NCT00251992","phase":"PHASE3","title":"Nexium Dyspepsia/AST","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2002-12","conditions":"Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia","enrollment":1200},{"nctId":"NCT00241540","phase":"PHASE3","title":"Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2001-01","conditions":"GERD","enrollment":808},{"nctId":"NCT00241553","phase":"PHASE3","title":"Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2001-04","conditions":"NSAIDs, Upper GI Symptoms","enrollment":276},{"nctId":"NCT00241527","phase":"PHASE3","title":"Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2000-12","conditions":"NSAIDs, Upper GI Symptoms","enrollment":556},{"nctId":"NCT00251901","phase":"PHASE3","title":"Chest Pain Pilot Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-05","conditions":"Chest Pain, Gastroesophageal Reflux","enrollment":600},{"nctId":"NCT00251914","phase":"PHASE3","title":"Nexium Dyspepsia/AST","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2002-12","conditions":"Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia","enrollment":1500},{"nctId":"NCT00241514","phase":"PHASE3","title":"Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2001-02","conditions":"GERD","enrollment":334},{"nctId":"NCT00427635","phase":"PHASE3","title":"Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-10","conditions":"GERD","enrollment":32},{"nctId":"NCT00542789","phase":"PHASE3","title":"Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-08","conditions":"Gastric Ulcer, Duodenal Ulcer, Rheumatoid Arthritis","enrollment":343},{"nctId":"NCT01107938","phase":"PHASE2","title":"Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients","status":"UNKNOWN","sponsor":"Livzon Pharmaceutical Group Inc.","startDate":"2010-05","conditions":"Gastroesophageal Reflux Disease","enrollment":330},{"nctId":"NCT00629512","phase":"PHASE3","title":"Prevention of Gastric Ulcers","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2001-03","conditions":"NSAID Associated Gastric Ulcers","enrollment":504},{"nctId":"NCT00628953","phase":"PHASE2","title":"Adult Asthmatics and Acid Reflux","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2002-10","conditions":"Asthma","enrollment":1400},{"nctId":"NCT00251966","phase":"PHASE3","title":"ASTERIX: Low Dose ASA and Nexium","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-05","conditions":"Gastroesophageal Reflux","enrollment":960},{"nctId":"NCT00626535","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2003-03","conditions":"Symptomatic Gastroesophageal Reflux Disease (sGERD)","enrollment":500},{"nctId":"NCT00574925","phase":"PHASE4","title":"Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2003-11","conditions":"Gastroesophageal Reflux Disease (GERD)","enrollment":""},{"nctId":"NCT00455754","phase":"PHASE3","title":"Esomeprazole Treatment for Patients With Lymphocytic Gastritis","status":"UNKNOWN","sponsor":"Technische Universität Dresden","startDate":"2007-02","conditions":"Lymphocytic Gastritis","enrollment":40},{"nctId":"NCT00365313","phase":"PHASE3","title":"Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2002-08","conditions":"Arthritis, Bleeding Ulcer","enrollment":273}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo"],"phase":"marketed","status":"active","brandName":"Placebo (for Esomeprazole)","genericName":"Placebo (for Esomeprazole)","companyName":"University of Malaya","companyId":"university-of-malaya","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control arm in esomeprazole clinical trials (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}